HB870

2026 Regular Session

HB870 by Representative Christopher Turner

INSURANCE/HEALTH: Provides relative to formulary placement and cost-sharing requirements for certain generic drugs and biosimilars (EG NO IMPACT See Note)

Current Status: Pending Senate referral - Sched. for 4/15/26

Text

House Floor Legislative Bureau Amendment #1716 Horton Proposed

House Floor Amendment #3620 Turner Proposed

House Committee Amendment #3003 INS Adopted

House Committee Amendment #1540 INS Draft

Digest of HB870 Reengrossed

Digest of HB870 Engrossed

Digest of HB870 Original

Fiscal Note - HB870 Engrossed

Fiscal Note - HB870 Original

House Vote on HB 870 FINAL PASSAGE (#466)

Christopher Turner (primary)

Date	Chamber	Journal Page	Action
04/14	S		Received in the Senate. Read first time by title and placed on the Calendar for a second reading.
04/13	H	48	Read third time by title, amended, roll called on final passage, yeas 96, nays 0. Finally passed, title adopted, ordered to the Senate.
04/13	H	47	Called from the calendar.
04/09	H		Scheduled for floor debate on 04/13/2026.
04/09	H	35	Notice given.
04/09	H	35	Read by title, returned to the calendar.
04/08	H		Scheduled for floor debate on 04/09/2026.
04/07	H	16	Read by title, amended, ordered engrossed, passed to 3rd reading.
04/01	H	69	Reported with amendments (10-0).
03/09	H	105	Read by title, under the rules, referred to the Committee on Insurance.
02/27	H		First appeared in the Interim Calendar on 2/27/2026.
02/27	H		Under the rules, provisionally referred to the Committee on Insurance.
02/27	H		Prefiled.